Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. 

Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. 

Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions.

[Mission]
We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities.

[Goal]
1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform.
2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.


AI/ML

Biotechnology

Health Care

Health Diagnostics

Medical Devices

NOUL Co., Ltd.

David Lim

Adam Balint

Seongjin Park

DongShik Ham

Youngmin Shin

YongJoon Kim

Simon Y. SHIN

Kyung-Hak Choi

Jungkwon Ahn

Jinwon Seo

The Engineering and Development team at NOUL Co., Ltd. is responsible for designing, developing, and enhancing the next-generation Point-Of-Care blood testing platform. This multidisciplinary team leverages expertise in hardware, software, artificial intelligence, and mechanical engineering to create innovative diagnostic solutions that improve healthcare accessibility. By focusing on cutting-edge technologies and rigorous testing, they ensure that Noul's platform meets high standards of quality and effectiveness in addressing global health challenges.

Engineering and Development

Sales and Marketing

Leadership Team

Engineering and Development

About

Team members

Other teams at NOUL Co., Ltd.

Sales and Marketing

Leadership Team